How The Famous Professor Damien Remède Discovered Schweppes Indian Tonic In The Peruvian Amazonia? You Won't Believe It ??
Ari Massoudi
I do stuff enabling Mankind to live longer, stronger and smarter ?????????=>??
The Epic Journey of Quinine: A Tale of Serendipity and Science
Legendary Origins
Imagine a lost traveler, feverish and desperate, wandering the dense, humid jungles of the Peruvian Amazon. Legend has it that this wanderer stumbled upon a pool of stagnant water, its surface reflecting the towering "quina quina" trees surrounding it. Driven by thirst, he drank deeply, fearing poison but finding salvation instead. His fever abated, and he returned to his village with tales of the bitter water and the miraculous tree. Whether this tale is true or not, the Quechua people of Peru had long used the bark of the quina quina tree to treat fevers and chills. Thus began the journey of quinine, a substance that would change the course of medical history.
The Countess and the Jesuits
The quina quina tree, later known as Cinchona, was named by the Swedish botanist Carl Linnaeus in honor of the Countess of Chinchon. The story goes that the countess, suffering from malaria, was cured by the bark of this tree. While this tale is more fable than fact, it was the Jesuit missionaries who played a pivotal role in bringing Cinchona bark to Europe. They learned of its healing properties from the native peoples and sent samples back to Rome. By the 17th century, "Jesuit's bark" was a celebrated cure for fevers, with recipes calling for it to be ground into a fine powder and mixed with strong wine to counteract its bitterness.
Malaria's Long Shadow
Malaria, derived from the Italian words "mal" and "aria," meaning "bad air," has plagued humanity for millennia. Spread by female Anopheles mosquitoes, the disease is caused by Plasmodium parasites, which attack red blood cells. The symptoms—fevers, chills, and sweats—can recur every second or third day, a cycle dependent on the specific parasite. Malaria is not contagious in the traditional sense; it requires an exchange of red blood cells, typically through a mosquito bite. Despite this, malaria claimed 405,000 lives in 2018, with most cases occurring in Africa. The disease has shaped human history, contributing to the fall of Rome and fueling the slave trade in the New World.
Uncovering the Secret of Cinchona
The secret behind Cinchona bark's healing properties was unveiled in 1820 by French toxicology professor Pierre Joseph Pelletier and his student Joseph Bienaimé Caventou. They isolated quinine, a yellow, sticky gum that dissolves readily in acid or alcohol. Quinine is an alkaloid, a naturally occurring chemical compound containing nitrogen atoms. This discovery allowed for standardized dosages, replacing the cumbersome method of ingesting copious amounts of dried bark in hot wine.
Quinine in War and Peace
Quinine's efficacy made it a strategic resource. During the American Civil War, Union soldiers received quinine rations, while the South smuggled it in through ingenious methods. In World War II, the Japanese seized the world's largest quinine producer, the Dutch factory on Java, leaving the Allies without a crucial supply. The United States launched the Cinchona Missions, a massive effort to secure Cinchona bark from South America. These missions were second only to the Manhattan Project in importance, involving agreements with countries like Colombia, Peru, and Ecuador, and expeditions led by U.S. botanists and foresters.
Beyond Malaria
Quinine's applications extend beyond malaria. It was the first drug used to treat lupus, an autoimmune disease, and has been used to treat rheumatoid arthritis since the mid-1950s. It is also used in combination with clindamycin for severe Babesia infections, a parasitic disease spread by ticks. Quinine's bitter taste is a key ingredient in tonic water and several liqueurs, although its over-the-counter sale for leg cramps was banned by the FDA in 1994 due to adverse effects.
The Dark Side of Quinine
Quinine has a narrow therapeutic window, meaning the difference between a safe dose and an overdose is small. "Cinchonism" refers to the aftereffects of a quinine overdose, which can include skin lesions, blurred vision, tinnitus, and abdominal issues. In severe cases, blindness can occur. Quinine is also linked to blackwater fever, a disease that causes red blood cells to rupture, releasing blood into the urine and often leading to renal failure.
The Rise of Synthetic Successors
Quinine's reign was eventually challenged by synthetic analogues like chloroquine. While quinine can be synthesized, it is a complex and costly process. Chloroquine, on the other hand, is easier to produce but has faced resistance from Plasmodium falciparum since the 1950s. Despite this, quinine remains a second-line treatment for malaria and a first-line treatment in resource-limited areas, particularly in Africa.
The Critique of Serendipity and the Promise of AI
The discovery of quinine, like many medical breakthroughs, was a product of serendipity and empirical practice. While these methods have yielded remarkable results, they are inherently unpredictable and inefficient. The future of medicine lies in the precision and speed of artificial intelligence (AI). AI can analyze vast amounts of data, identify patterns, and predict outcomes with unprecedented accuracy. If researchers had access to AI during the discovery of quinine, the process would have been accelerated, and the history of malaria treatment would have been vastly different. AI could have identified the active compounds in Cinchona bark more quickly, optimized dosages, and predicted resistance patterns.
A New Era of Discovery
In a world where AI drives medical discovery, the story of quinine would be one of calculated precision rather than lucky accidents. The legends of lost travelers and miraculous cures would be replaced by tales of algorithms and data-driven insights. The history of quinine would not be a tale of centuries-long journeys but a testament to the power of technology to transform our understanding of disease and its treatment.
If you're interested by AI-driven drug discovery ??????
ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery
Exciting news! ?? Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!
?? From Academia to AI-Powered Drug Discovery
Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.
?? Unveiling Cortex Discovery's Innovative Approach
Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:
? Their foundation model for drug property predictions
? The vast database of 750 million data points powering their deep learning system
? Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism
?? Business Insights and Future Outlook
Get an insider's perspective on:
? Cortex Discovery's unique business model and collaboration opportunities
? Challenges faced in the AI-driven drug discovery landscape
? The company's vision for the future of longevity research and pharmaceutical development
This episode is a must-watch for:
? Biotech and pharmaceutical executives
? Investors in the life sciences sector
? Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine
? Anyone interested in the intersection of AI and drug discovery
Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!